{"id":517250,"date":"2021-07-26T06:03:26","date_gmt":"2021-07-26T10:03:26","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\/"},"modified":"2021-07-26T06:03:26","modified_gmt":"2021-07-26T10:03:26","slug":"brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\/","title":{"rendered":"BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">NEW YORK<\/span>, <span class=\"xn-chron\">July 26, 2021<\/span> \/PRNewswire\/ &#8211;BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today that the Company will hold a conference call to update shareholders on financial results for the second quarter ended <span class=\"xn-chron\">June 30, 2021<\/span>, and provide a corporate update, at <span class=\"xn-chron\">8:00 a.m. Eastern Time<\/span> on <span class=\"xn-chron\">August 05, 2021<\/span>.<\/p>\n<div id=\"prni_dvprnejpge40aleft\" dir=\"ltr\">\n        <img decoding=\"async\" id=\"prnejpge40aleft\" title=\"BrainStorm Cell Therapeutics Logo\" border=\"0\" alt=\"BrainStorm Cell Therapeutics Logo\" align=\"middle\" src=\"https:\/\/mma.prnewswire.com\/media\/1166536\/BrainStorm_Logo.jpg\" \/>\n      <\/div>\n<p>BrainStorm&#8217;s Chief Executive Officer, <span class=\"xn-person\">Chaim Lebovits<\/span>, will present a corporate update after which participant questions will be answered. Joining Mr. Lebovits to answer investment community questions will be <span class=\"xn-person\">Ralph Kern<\/span>, MD, MHSc, President and Chief Medical Officer, <span class=\"xn-person\">Stacy Lindborg<\/span>, PhD, Executive Vice President and Global Head of Clinical Research, <span class=\"xn-person\">David Setboun<\/span>, PharmD, MBA, Executive Vice President and Chief Operating Officer, and <span class=\"xn-person\">Preetam Shah<\/span>, PhD, MBA, Executive Vice President and Chief Financial Officer.<\/p>\n<p>Participants are encouraged to submit their questions prior to the call by sending them to:\u00a0<a target=\"_blank\" href=\"mailto:q@brainstorm-cell.com\" rel=\"nofollow noopener\">q@brainstorm-cell.com<\/a>. Questions should be submitted by <span class=\"xn-chron\">5:00 p.m. Eastern Time on Wednesday<\/span>, August 4, 2021.<\/p>\n<p>The investment community may participate in the conference call by dialing the following numbers:<\/p>\n<p>\n        <u>Participant Numbers:<\/u><br \/>\n        <br \/>Toll Free: 888-506-0062\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 <br \/>International:\u00a0973-528-0011\u00a0 <br \/>Entry Code: 298566<\/p>\n<p>Webcast URL:\u00a0<a target=\"_blank\" href=\"https:\/\/shared.outlook.inky.com\/link?domain=www.webcaster4.com&amp;t=eyJ0eXAiOiJKV1QiLCJhbGciOiJFUzI1NiJ9.eJxtkEFvwjAMhf9LzoxCYAcqTWITG9pE0zEVlVSVkEnMGkhLlaQUddp_X8pu0462nz8_vy_iEEolSUi0OqAVCuRF2bOxZEBU5dBUoEl4AG1xQNDLaltAMd8bUJV1Z1PeCdR6KM6lX-gx_08a4ymkcK62YR7kQdu2wxb3Aqw_Me1FeZD-1nnwDp-YB3RyP82D6XhGZx4Qb0hYNVoPiCsMgttpvKBnjrzN29mlLrMtO0L6cpKl7vaTt25F2Ylvs1qMniykmRaU1Tz9oLBlF1FFDaczt-o2XZRmJTuuR2wZtSx5pGzBxzzRRZzIIkp9n66vvNtMVt0zjY78Gi9OlCWiiRevD_1vFs0OS1B6B1IatNb7ERJ8jvM_od7S-P4B-09_kg.MEUCIQCph3if_L_mvYt5At1SdZewa11G90UXds5Vaic5mFNAoAIgTK7D5z2IoxzAWkNPrsAOzcBytWmmpkC2NtWOTniabNo\" rel=\"nofollow noopener\">https:\/\/www.webcaster4.com\/Webcast\/Page\/2354\/41929<\/a>\u00a0\u00a0<\/p>\n<p>Those interested in listening to the conference call live via the internet may do so by using the webcast link above or by visiting the &#8220;Investors &amp; Media&#8221; page of BrainStorm&#8217;s website at\u00a0<a target=\"_blank\" href=\"https:\/\/ir.brainstorm-cell.com\/overview\" rel=\"nofollow noopener\">https:\/\/ir.brainstorm-cell.com\/overview<\/a> and clicking on the conference call link.<\/p>\n<p>Those that wish to listen to the replay of the conference call can do so by dialing the numbers below. The replay will be available for 14 days.<\/p>\n<p>\n        <u>Replay Numbers:<\/u><br \/>\n        <br \/>Toll Free: 877-481-4010\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 <br \/>International:\u00a0919-882-2331\u00a0 <br \/>Replay Passcode:\u00a041929\u00a0 <\/p>\n<p>\n        <b>About NurOwn\u00ae\u00a0 <\/b>\n      <\/p>\n<p>The NurOwn\u00ae technology platform (autologous MSC-NTF cells) represents a promising investigational therapeutic approach to targeting disease pathways important in neurodegenerative disorders. MSC-NTF cells are produced from autologous, bone marrow-derived mesenchymal stem cells (MSCs) that have been expanded and differentiated ex vivo. MSCs are converted into MSC-NTF cells by growing them under patented conditions that induce the cells to secrete high levels of neurotrophic factors (NTFs). Autologous MSC-NTF cells are designed to effectively deliver multiple NTFs and immunomodulatory cytokines directly to the site of damage to elicit a desired biological effect and ultimately slow or stabilize disease progression.<\/p>\n<p>\n        <b>About BrainStorm Cell Therapeutics Inc.<\/b>\n      <\/p>\n<p>BrainStorm Cell Therapeutics Inc. is a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases. The Company holds the rights to clinical development and commercialization of the NurOwn\u00ae technology platform used to produce autologous MSC-NTF cells through an exclusive, worldwide licensing agreement. Autologous MSC-NTF cells have received Orphan Drug designation status from the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of amyotrophic lateral sclerosis (ALS). BrainStorm has completed a Phase 3 pivotal trial in ALS (NCT03280056); this trial investigated the safety and efficacy of repeat-administration of autologous MSC-NTF cells and was supported by a grant from the California Institute for Regenerative Medicine (CIRM CLIN2-0989). BrainStorm completed under an investigational new drug application a Phase 2 open-label multicenter trial (NCT03799718) of autologous MSC-NTF cells in progressive multiple sclerosis (MS).<\/p>\n<p>For more information, visit the company&#8217;s website at\u00a0<a target=\"_blank\" href=\"http:\/\/www.brainstorm-cell.com\/\" rel=\"nofollow noopener\">www.brainstorm-cell.com<\/a>.<\/p>\n<p>\n        <b>Contacts<br \/><\/b>Investor Relations:<br \/><span class=\"xn-person\">John Mullaly<\/span><br \/>LifeSci Advisors, LLC<br \/>Phone: +1 617-430-7485<br \/><a target=\"_blank\" href=\"mailto:jmullaly@lifesciadvisors.com\" rel=\"nofollow noopener\">jmullaly@lifesciadvisors.com<\/a>\u00a0<\/p>\n<p>\n        <b>Media:<br \/><\/b><br \/>\n        <span class=\"xn-person\">Paul Tyahla<\/span><br \/>\n        <br \/>SmithSolve<br \/>Phone: + 1.973.713.3768<br \/><a target=\"_blank\" href=\"mailto:Paul.tyahla@smithsolve.com\" rel=\"nofollow noopener\">Paul.tyahla@smithsolve.com<\/a><\/p>\n<p>Logo &#8211; <a target=\"_blank\" href=\"https:\/\/mma.prnewswire.com\/media\/1166536\/BrainStorm_Logo.jpg\" rel=\"nofollow noopener\">https:\/\/mma.prnewswire.com\/media\/1166536\/BrainStorm_Logo.jpg<\/a><\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LN53651&amp;sd=2021-07-26\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update-301340822.html\">https:\/\/www.prnewswire.com\/news-releases\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update-301340822.html<\/a><\/p>\n<p>SOURCE  Brainstorm Cell Therapeutics Inc<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LN53651&amp;Transmission_Id=202107260600PR_NEWS_USPR_____LN53651&amp;DateId=20210726\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK, July 26, 2021 \/PRNewswire\/ &#8211;BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today that the Company will hold a conference call to update shareholders on financial results for the second quarter ended June 30, 2021, and provide a corporate update, at 8:00 a.m. Eastern Time on August 05, 2021. BrainStorm&#8217;s Chief Executive Officer, Chaim Lebovits, will present a corporate update after which participant questions will be answered. Joining Mr. Lebovits to answer investment community questions will be Ralph Kern, MD, MHSc, President and Chief Medical Officer, Stacy Lindborg, PhD, Executive Vice President and Global Head of Clinical Research, David Setboun, PharmD, MBA, Executive Vice President and Chief Operating &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-517250","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK, July 26, 2021 \/PRNewswire\/ &#8211;BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today that the Company will hold a conference call to update shareholders on financial results for the second quarter ended June 30, 2021, and provide a corporate update, at 8:00 a.m. Eastern Time on August 05, 2021. BrainStorm&#8217;s Chief Executive Officer, Chaim Lebovits, will present a corporate update after which participant questions will be answered. Joining Mr. Lebovits to answer investment community questions will be Ralph Kern, MD, MHSc, President and Chief Medical Officer, Stacy Lindborg, PhD, Executive Vice President and Global Head of Clinical Research, David Setboun, PharmD, MBA, Executive Vice President and Chief Operating &hellip; Continue reading &quot;BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-26T10:03:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1166536\/BrainStorm_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update\",\"datePublished\":\"2021-07-26T10:03:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\\\/\"},\"wordCount\":586,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1166536\\\/BrainStorm_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\\\/\",\"name\":\"BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1166536\\\/BrainStorm_Logo.jpg\",\"datePublished\":\"2021-07-26T10:03:26+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1166536\\\/BrainStorm_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1166536\\\/BrainStorm_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\/","og_locale":"en_US","og_type":"article","og_title":"BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update - Market Newsdesk","og_description":"PR Newswire NEW YORK, July 26, 2021 \/PRNewswire\/ &#8211;BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today that the Company will hold a conference call to update shareholders on financial results for the second quarter ended June 30, 2021, and provide a corporate update, at 8:00 a.m. Eastern Time on August 05, 2021. BrainStorm&#8217;s Chief Executive Officer, Chaim Lebovits, will present a corporate update after which participant questions will be answered. Joining Mr. Lebovits to answer investment community questions will be Ralph Kern, MD, MHSc, President and Chief Medical Officer, Stacy Lindborg, PhD, Executive Vice President and Global Head of Clinical Research, David Setboun, PharmD, MBA, Executive Vice President and Chief Operating &hellip; Continue reading \"BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-26T10:03:26+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1166536\/BrainStorm_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update","datePublished":"2021-07-26T10:03:26+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\/"},"wordCount":586,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1166536\/BrainStorm_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\/","name":"BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1166536\/BrainStorm_Logo.jpg","datePublished":"2021-07-26T10:03:26+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1166536\/BrainStorm_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1166536\/BrainStorm_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brainstorm-to-announce-second-quarter-financial-results-and-provide-a-corporate-update\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/517250","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=517250"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/517250\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=517250"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=517250"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=517250"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}